| 1 |
31586149 | In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site. | 2020 Feb |
1 |
| 2 |
31637414 | Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria. | 2020 Apr 15 |
3 |
| 3 |
31714193 | MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization. | 2020 Jan |
1 |
| 4 |
31726354 | Development of a Microfluidic Culture Paradigm for Ex Vivo Maintenance of Human Glioblastoma Tissue: A New Glioblastoma Model? | 2020 Jan |
1 |
| 5 |
31833548 | The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas. | 2020 Aug 1 |
1 |
| 6 |
31908598 | Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas. | 2020 |
1 |
| 7 |
31929772 | Alterations of Mitochondria and Related Metabolic Pathways in Leukemia: A Narrative Review. | 2020 Jan-Apr |
1 |
| 8 |
31935911 | Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth. | 2020 Jan 6 |
1 |
| 9 |
31963507 | Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells. | 2020 Jan 17 |
1 |
| 10 |
31969485 | The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas. | 2020 Jan 22 |
2 |
| 11 |
32003035 | In vivo MRS measurement of 2-hydroxyglutarate in patient-derived IDH-mutant xenograft mouse models versus glioma patients. | 2020 Sep |
1 |
| 12 |
32025842 | Updates on DNA methylation modifiers in acute myeloid leukemia. | 2020 Apr |
1 |
| 13 |
32027343 | Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. | 2020 Apr 1 |
1 |
| 14 |
32055803 | Ivosidenib to treat adult patients with relapsed or refractory acute myeloid leukemia. | 2020 Jan |
1 |
| 15 |
31632056 | Detection Of Mutations In The Isocitrate Dehydrogenase Genes (IDH1/IDH2) Using castPCRTM In Patients With AML And Their Clinical Impact In Mexico City. | 2019 |
2 |
| 16 |
31660152 | Isocitrate dehydrogenase inhibitors in acute myeloid leukemia. | 2019 |
2 |
| 17 |
31742037 | Maffucci Syndrome with Clival Enchondroma in Nasopharynx: A Case Report. | 2019 Oct |
1 |
| 18 |
31795195 | Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma. | 2019 Nov 28 |
1 |
| 19 |
31810230 | Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status. | 2019 Dec 2 |
1 |
| 20 |
31888244 | Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin. | 2019 Dec 16 |
1 |
| 21 |
31907132 | [Value of Serum Tumor Marker Isocitrate Dehydrogenase 1 in the Diagnosis of Lung Cancer]. | 2019 Dec 30 |
1 |
| 22 |
31921378 | Bone Marrow Features in Patients With Acute Myeloid Leukemia Treated With Novel Targeted Isocitrate Dehydrogenase 1/2 Inhibitors. | 2019 Dec |
1 |
| 23 |
31921684 | Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses. | 2019 |
1 |